| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
867,229 |
| 52
Week Range: |
$187.64 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
19,405 |
57,754 |
513,978 |
| Total Sell Value |
$0 |
$4,136,219 |
$11,851,618 |
$91,955,621 |
| Total People Sold |
0 |
2 |
7 |
9 |
| Total Sell Transactions |
0 |
2 |
21 |
74 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Himes Vaughn B |
Chief Technical Officer |
• – – |
2023-09-07 |
4 |
OE |
$44.09 |
$387,331 |
D/D |
8,785 |
60,224 |
|
- |
|
| Liu Jean I |
Chief Legal Officer |
• – – |
2023-08-31 |
4 |
AS |
$206.97 |
$391,786 |
D/D |
(1,893) |
84,462 |
|
11% |
|
| Romp Charles R |
EVP, Commercial U.S. |
• – – |
2023-08-31 |
4 |
AS |
$206.97 |
$114,866 |
D/D |
(555) |
69,156 |
|
11% |
|
| Romp Charles R |
EVP, Commercial U.S. |
• – – |
2023-08-29 |
4 |
AS |
$206.00 |
$90,228 |
D/D |
(438) |
69,711 |
|
11% |
|
| Dansey Roger D |
President, R&D & CMO |
• – – |
2023-08-29 |
4 |
AS |
$206.00 |
$209,296 |
D/D |
(1,016) |
115,797 |
|
11% |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2023-08-29 |
4 |
AS |
$206.00 |
$99,910 |
D/D |
(485) |
130,925 |
|
11% |
|
| Liu Jean I |
Chief Legal Officer |
• – – |
2023-08-29 |
4 |
AS |
$206.00 |
$83,430 |
D/D |
(405) |
86,355 |
|
11% |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2023-08-29 |
4 |
AS |
$206.00 |
$76,426 |
D/D |
(371) |
53,234 |
|
11% |
|
| Romp Charles R |
EVP, Commercial U.S. |
• – – |
2023-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,107 |
70,149 |
|
- |
|
| Dansey Roger D |
President, R&D & CMO |
• – – |
2023-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,872 |
116,813 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2023-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,225 |
131,410 |
|
- |
|
| Liu Jean I |
Chief Legal Officer |
• – – |
2023-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,022 |
86,760 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2023-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
937 |
53,605 |
|
- |
|
| Welch Daniel G |
Director |
– • – |
2023-08-28 |
4 |
AS |
$209.08 |
$336,619 |
I/I |
(1,610) |
10,725 |
|
11% |
|
| Welch Daniel G |
Director |
– • – |
2023-08-28 |
4 |
AS |
$209.01 |
$693,094 |
D/D |
(3,315) |
6,794 |
|
11% |
|
| Welch Daniel G |
Director |
– • – |
2023-08-28 |
4 |
OE |
$135.63 |
$245,762 |
D/D |
1,812 |
10,109 |
|
- |
|
| Liu Jean I |
Chief Legal Officer |
• – – |
2023-08-16 |
4 |
D |
$193.87 |
$583,158 |
D/D |
(3,008) |
85,738 |
|
- |
|
| Romp Charles R |
EVP, Commercial |
• – – |
2023-08-16 |
4 |
D |
$193.87 |
$607,585 |
D/D |
(3,134) |
69,042 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2023-08-16 |
4 |
D |
$193.87 |
$528,293 |
D/D |
(2,725) |
52,668 |
|
- |
|
| Dansey Roger D |
President, R&D & CMO |
• – – |
2023-08-16 |
4 |
D |
$193.87 |
$1,987,544 |
D/D |
(10,252) |
114,941 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2023-08-16 |
4 |
D |
$193.87 |
$679,898 |
D/D |
(3,507) |
130,185 |
|
- |
|
| Liu Jean I |
Chief Legal Officer |
• – – |
2023-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,107 |
88,746 |
|
- |
|
| Romp Charles R |
EVP, Commercial |
• – – |
2023-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,107 |
72,176 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2023-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,469 |
55,393 |
|
- |
|
| Dansey Roger D |
President, R&D & CMO |
• – – |
2023-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,747 |
125,193 |
|
- |
|
1805 Records found
|
|
Page 2 of 73 |
|
|
